These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8442139)

  • 1. Allograft biopsies in situ hybridization HBVDNA detection of serum HBs Ag-repositive patients treated with anti-HBV immunoprophylaxis after liver transplantation for HBV cirrhosis.
    Reynès M; Tricottet V; Samuel D; Sebagh M; Bismuth A; Arulnaden J; Brechot C; Bismuth H
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1347-8. PubMed ID: 8442139
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis.
    Samuel D; Zignego AL; Reynes M; Feray C; Arulnaden JL; David MF; Gigou M; Bismuth A; Mathieu D; Gentilini P
    Hepatology; 1995 Feb; 21(2):333-9. PubMed ID: 7843702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum.
    Mariscal LF; Rodríguez-Iñigo E; Bartolomé J; Castillo I; Ortiz-Movilla N; Navacerrada C; Pardo M; Pérez-Mota A; Graus J; Carreño V
    J Med Virol; 2004 Jun; 73(2):177-86. PubMed ID: 15122790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoprophylaxis for hepatitis B virus reinfection after liver transplantation.
    Jeng LB; Lee WC; Yeh DS; Wang CC; Wang KL; Chen SC; Chen MF; Chien RN; Chiu CT; Lin DY
    Transplant Proc; 1994 Aug; 26(4):2243-4. PubMed ID: 8066736
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis gene chip in detecting HBV DNA, HCV RNA in serum and liver tissue samples of hepatitis patients.
    Zhao W; Wan JM; Liu W; Liu QJ; Zhang L; Zhou ZX; Liu XJ; Zhang HR
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):234-41. PubMed ID: 14599976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term passive immunoprophylaxis of B virus recurrence after liver transplantation in HBs antigen-positive patients.
    Gugenheim J; Crafa F; Fabiani P; Goubaux B; Ouzan D; Mouiel J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1349-50. PubMed ID: 8442140
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
    Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
    Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of hepatitis B virus in the liver of chronic hepatitis C patients with occult hepatitis B virus infection.
    Rodríguez-Iñigo E; Mariscal L; Bartolomé J; Castillo I; Navacerrada C; Ortiz-Movilla N; Pardo M; Carreño V
    J Med Virol; 2003 Aug; 70(4):571-80. PubMed ID: 12794719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the changes of HBV serum markers and HBV DNA and the effects of perioperative factors after liver transplantation].
    Tang YM; Chen GH; He XS; Zhu XF; Chen MH
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):164-7. PubMed ID: 15760545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of the hepatitis B virus-DNA concentration in patients after orthotopic liver transplantation.
    Zöllner B; Polywka S; Feucht HH; Martens H; Iske L; Oehler G; Laufs R
    Hepatogastroenterology; 1994 Oct; 41(5):424-6. PubMed ID: 7851849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful retransplantation for recurrent posttransplant hepatitis B virus infection in the primary allograft.
    Ishitani M; McGory R; Dickson R; Caldwell S; Bickston S; McCullough C; Pruett T
    Transplant Proc; 1996 Jun; 28(3):1714-6. PubMed ID: 8658852
    [No Abstract]   [Full Text] [Related]  

  • 13. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
    J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fialuridine on hepatitis B immune globulin pharmacokinetics following orthotopic liver transplant for chronic hepatitis B viral-induced cirrhosis.
    McGory RW; Ishitani MB; Oliveira WM; Stevenson WC; Dickson RC; Caldwell SH; Pruett TL
    Transplant Proc; 1995 Feb; 27(1):1213-4. PubMed ID: 7878854
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
    Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ
    J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic alteration of HBV markers on active HBV replicative recipients after liver transplantation: a preliminary report.
    Lu SC; Yan LN; Li B; Ma YK; Liu C; Wen TF; Lin QY; Zhao JC; Wang XB; Li XD; Qing S; Zhao LS; Liu C; Liu J; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):196-201. PubMed ID: 14599968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retransplantation of patients with severe posttransplant hepatitis B in the first allograft.
    Ishitani M; McGory R; Dickson R; Caldwell S; Bickston S; McCullough C; Pruett T; Terrault N; Roberts J; Ascher N; Wright T; Lake J
    Transplantation; 1997 Aug; 64(3):410-4. PubMed ID: 9275104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin.
    Terrault NA; Zhou S; Combs C; Hahn JA; Lake JR; Roberts JP; Ascher NL; Wright TL
    Hepatology; 1996 Dec; 24(6):1327-33. PubMed ID: 8938155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B-associated liver cirrhosis as an indication for liver transplantation.
    Jansen PL; Haagsma EB; Klompmaker IJ; Cuypers HT; Karrenbeld A; Gouw AS; Slooff MJ
    Scand J Gastroenterol Suppl; 1995; 212():19-22. PubMed ID: 8578227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen.
    Murakami Y; Minami M; Daimon Y; Okanoue T
    J Med Virol; 2004 Feb; 72(2):203-14. PubMed ID: 14695661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.